High Tower Advisors, LLC Provention Bio, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$4.52 - $10.57 $9,966 - $23,306	2,205 Added 9.34%	25,820 $272,000
Q2 2022 Aug 10, 2022	SELL	$3.65 - $7.3 $182 - $365	-50 Reduced 0.21%	23,615 $95,000
Q1 2022 May 12, 2022	BUY	$3.4 - $7.88 $80,461 - $186,480	23,665 New	23,665 $174,000
Q4 2021 Feb 10, 2022	SELL	$5.59 - $7.39 $132,013 - $174,522	-23,616 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $5,094 - $7,497	900 Added 3.96%	23,616 $151,000
Q2 2021 Aug 06, 2021	BUY	$6.71 - $11.04 $43,051 - $70,832	6,416 Added 39.36%	22,716 $191,000
Q1 2021 May 10, 2021	BUY	$10.12 - $19.45 $164,956 - $317,035	16,300 New	16,300 $171,000
Q4 2018 Feb 14, 2019	SELL	$1.73 - $4.0 $60,631 - $140,188	-35,047 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$3.4 - $4.81 $119,159 - $168,576	35,047 New	35,047 $141,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.